Experimentica will attend 62nd SOT and ToxExpo | Booth #1532

Authors' picture

By Experimentica on March 7, 2023
Team

Summary: Meet us at booth #1532 and find out more about Experimentica's R&D and services in ocular Toxicology and PK.

Content

Experimentica’s scientific and business development teams will attend the 62nd annual Society Of Toxicology and ToxExpo in Nashville, TN, from March 17 to 23.

This event brings together 5,000+ toxicologists and those working in areas related to toxicology to share the latest science and technology in the field, as well as to make new connections, gather with friends, and engage in mentoring and professional development.

Featured Posters

Do not miss out on our team’s posters in ocular toxicology and preclinical model development.

A B S T R A C T

Subchronic systemic alcohol exposure results in ocular toxicity

Authors: Kaja S, Cesna R, Neverauskas D, Iqbal S, Ragauskas S, Ghosh AK

Purpose: A strong clinical association exists between acute and chronic alcohol consumption and incidence of ocular surface disease. The goal of this study was to investigate the toxicological and pathophysiological effects of alcohol consumption on the ocular surface in vitro and in vivo.

A B S T R A C T

Topical porphyrin antioxidant alleviates allergic conjunctivitis in environmental toxin exposure to particulate matter

Authors: Iqbal S, Ghosh AK, Bacellar-Galdino M, Pappenhagen NE, Kaja S

Purpose: Exposure to environmental toxin particulate matter (PM) is associated with the development of acute and chronic ocular surface disease, including allergic conjunctivitis. The purpose of this study was to investigate cytotoxicity and ocular surface pathology in response to PM exposure. We developed a novel preclinical PM-induced allergic conjunctivitis model in rabbits and evaluated the pharmacologic efficacy of an experimental topical porphyrin antioxidant, manganese (III) tetrakis(1-methyl-4-pyridyl) porphyrin (Mn-TM-2-PyP) and lifitegrast (Xiidra®).

Meet with us in Nashville, TN


Whether you have a question about our science, preclinical models, capabilities, pricing or anything else, our senior management and business development team is ready to answer your inquiries.

Authors' picture